Speakers

​Carla Spina PhD, is a scientific innovator and entrepreneur with over 20+ years of experience in drug and combination therapeutics. With experience from early to commercial stage programs, Carla led the lead development of 5 drug-device product through global commercialization in over 9 countries and the successful financing for FIH trials for topical ABSSSI therapeutic within metabolically compromised patients. She brings these diverse qualifications, scientific rigor, and progressive thinking to her leadership role as CEO and Co-Founder at Noa Therapeutics. Combining her exceptional ability to build global cross-functional teams and inspire collaboration between thought leaders, Carla is advancing her strategic vision to deliver truly innovative and impactful solutions to patients living with chronic inflammatory disease.